Search by Drug Name or NDC
NDC 70000-0056-01 Leader Chest Congestion Relief 20; 400 mg/1; mg/1 Details
Leader Chest Congestion Relief 20; 400 mg/1; mg/1
Leader Chest Congestion Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Cardinal Health. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 70000-0056-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 70000-0056-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 70000-0056 |
|---|---|
| Product ID | 70000-0056_8d2e88f2-eef4-42dd-842d-97783af92136 |
| Associated GPIs | 43997002520345 |
| GCN Sequence Number | 058386 |
| GCN Sequence Number Description | guaifenesin/dextromethorphan TABLET 400MG-20MG ORAL |
| HIC3 | B3T |
| HIC3 Description | NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION |
| GCN | 23807 |
| HICL Sequence Number | 000223 |
| HICL Sequence Number Description | GUAIFENESIN/DEXTROMETHORPHAN HBR |
| Brand/Generic | Generic |
| Proprietary Name | Leader Chest Congestion Relief |
| Proprietary Name Suffix | DM |
| Non-Proprietary Name | Dextromethorphan Hydrobromide / Guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20; 400 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Labeler Name | Cardinal Health |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70000-0056-01 (70000005601)
| NDC Package Code | 70000-0056-1 |
|---|---|
| Billing NDC | 70000005601 |
| Package | 1 BOTTLE in 1 CARTON (70000-0056-1) / 60 TABLET in 1 BOTTLE |
| Marketing Start Date | 2020-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.08293 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CHEST CONG RLF DM 400-20 MG TB |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |